Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.
Company driver Steve Karandy, 59, suffers from two stress-related illnesses: obesity and hypertension. While nearly half (44%) of survey respondents said they don’t suffer from any stress-related ...